AIOCD Raises Alarm Over AI-Generated Fake Prescriptions

The All India Organisation of Chemists and Druggists (AIOCD) has issued a stark warning regarding the rampant misuse of Artificial Intelligence (AI) in generating fraudulent medical prescriptions. This troubling trend facilitates the illegal online sale of controlled substances, including antibiotics, psychotropic drugs, and opioids. The AIOCD’s President, J S Shinde, and General Secretary, Rajiv Singhal, highlighted findings from a recent media investigation that revealed AI-generated prescriptions containing fabricated hospital information are being accepted by various online platforms.

The organization pointed out that illegal e-pharmacies are exploiting Government Notifications GSR 817(E) and GSR 220(E) to bypass the safeguards established under the Drugs and Cosmetics Act, 1940. Unlike traditional brick-and-mortar chemists, online pharmacies often lack rigorous human verification processes. As a result, it has become exceedingly difficult to identify these AI-generated fake prescriptions, posing a significant risk to public health.

AIOCD has called on the government to take immediate action by revoking the aforementioned notifications, shutting down illegal e-pharmacies, and declaring all AI-generated prescriptions invalid nationwide. This request comes as the AIOCD previously urged Prime Minister Narendra Modi in February 2024 to implement stringent measures against the unregulated sale of antibiotics without valid prescriptions. The organization expressed concern that such practices contribute to the acceleration of Antimicrobial Resistance (AMR), a growing public health crisis.

In a recent address, Prime Minister Modi emphasized the need to control the unrestrained sale of antibiotics, aligning with the AIOCD’s concerns. The AIOCD noted that research from the Indian Council of Medical Research (ICMR) classifies this issue as a national health emergency. The widespread and indiscriminate use of commonly prescribed antibiotics for conditions such as pneumonia and urinary tract infections is rendering these medications ineffective, raising alarms within the medical community.

The AIOCD’s proactive stance is underscored by its commitment to safeguarding public health and ensuring that medical regulations are adhered to rigorously. The organization argues that the intersection of technology and healthcare must be carefully monitored to prevent misuse that could have dire consequences for patients and the healthcare system as a whole.

As the situation develops, the AIOCD is poised to work closely with government authorities to combat the illegal online drug trade and protect consumers from the dangers posed by fake prescriptions. The urgent nature of this issue underscores the need for collaborative efforts to enhance regulatory frameworks and ensure that technological advancements in healthcare do not compromise patient safety.